Ms. Laurence Legout

Brief Biography:

En 2012:
− Antibioprophylaxie dentaire chez les patients porteurs d’une infection de prothèse : définitivement non. L Legout, E Beltrand, H Migaud, E Senneville. RCO 2012.
- First Initial community-acquired meningitis due to Escherichia coli producing extended-spectrum-beta-lactamase complicated with multiple aortic mycotic aneurysms. P Weyrich, N Ettahar, L Legout, A Meybeck, O Leroy, E Senneville. Ann clin microbiology antimicrob 2011, in press. Impact factor 2010: 1.7
- Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 1 year cohort study. L. Legout, PV D’Elia, P Devos, N Ettahar, B Sarraz-Bournet, S Haulon, E Senneville, O Leroy. J Infect 2012, in press. Impact factor 2010: 3,805
- Diagnostic et traitement des infections de prothèses vasculaires. L legout, PV d’Elia, B Sarraz-bournet, S haulon, A meybeck, E senneville, O leroy. Med mal Inf 2012. In press. Impact factor 2010 : 0.484
- Vascular graft infections. O Leroy, A Meybeck, B Sarraz-Bournet, PV d’Elia, L Legout. Current opinion infectious diseases 2011, in press. Impact factor 2010:5,165

En 2011:
- Factors governing the healing of staphylococcus aureus infections following hip and knee prosthesis implantation: a retrospective study of 95 patients. D Joulie, J Girard, O Mares, E beltrand, L Legout, H Dezeque, H Migaud, E Senneville. Orthop Traumatol Surg Res. 2011. In press. Impact factor 2010: 0.52
− Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot. E Senneville, D Gaworowska, H Topolinski , F Devemy, S Nguyen, B Singer, E Beltrand, L Legout, M Caillaux, D Descamps, JP Canonne, Y Yazdanpanah. Diabet med 2011. In press Impact factor 2010: 2.87
- Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus. E Senneville, D Joulie, L Legout, M Valette, H Dezeque, E Beltrand, B Rosele, T d'Escrivan, C Loiez, M Caillaux, Y Yazdanpanah, C Maynou, H Migaud. Clin infect dis. 2011; 53(4):334–340. Impact factor 2010: 8.186
- Characteristic and prognosis in patients with prosthetic vascular graft infection: a prospective cohort study. L Legout, Sarraz-Bournet B, Delia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O. Clin microb infect 2011, in press. Impact factor 2010: 4.784
- A Prevotat, S Bonne, N Viziris, Y Yazdanpanah, E Senneville, L Legout. Efficacité de l’association tigécycline-amikacine-cefoxitime chez une patiente diabétique traitée pour une infection pulmonaire à Mycobacterium abcessus. Med Mal Infect 2011 ;41(8) :446-8. Impact factor 2010 : 0.484
- N Baclet, S Haeghebaert, L Legout, M Caillaux, S Moreau-crepeaux, A Vachee, E senneville, P Chaud, Y yazdanpanah, J Poissy. Cas groupés de fièvre typhoïde autochtone sur la métropole lilloise : janvier-mars 2009. Med Mal Infect 2011, 41(5) :248-52 Impact factor 2010 : 0.484

En 2010 :
- Szczot M, Meybeck A, Legout L, Pasquet A, Van Grunderbeeck N, Langlois J, Sarraz-Bournet B, Devos P, Leroy O. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect 2010;62(3):204-11. Impact factor 2010: 3.805
- J Bloch, X Lemaire, L Legout, D Ferriby, Y Yazdanpanah, E Senneville. Brain abscesses during Proteus vulgaris Bacteremia. Neurol Sci 2010;32(4):661-3. Impact factor 2010: 1.22
- L Legout, M Valette, H Dezeque, S Nguyen, X Lemaire, C Loiez, M Caillaux, E Beltrand, L Dubreuil, Y Yazdanpanah, H Migaud, E Senneville. Tolerability of prolonged linezolid in bone and joint infections: protective effect of rifampicin on the occurrence of anaemia ? J Antimicrob Chemother 2010 ;65(10) :224-30. Impact factor 2010 : 4.659
- L Bernard, L Legout, R Stern, L Zürcher-Pfund, A Lübbeke, P Rohner, R Peter, M Assal, D Lew, P Hoffmeyer, I Uçkay. Surgery and six weeks’ antibiotic treatment are sufficient for prosthetic infections of the hip and knee. J Infect 2010;61(2):125-32. Impact factor 2010 : 3.805
- D Simanaityte, N Le Gouellec, F Ajana, N Baclet, J Poissy, A Laiskonis, A Mickiene, E Senneville, Y Yazdanpanah, L Legout. Primo-infection toxoplasmique avec atteinte pulmonaire chez un immunocompétent. Med mal infect 2010; 40 :713-5 Impact factor 2010 : 0.484
- O Simon, E Senneville, M Caillaux, Y Yazdanpanh, L Legout. Abcès cutanés multiples à Aggregatibacter actinomycetemcomitans. Med mal infect 2010 ;40(8) :495-6. Impact factor 2010 : 0.484
- O Robineau, J Enrico, X lemaire, J Poissy, L Legout, E Senneville, JF Colombel, Y Yazdanpanah. Herpes Simplex Virus Meningo-Encephalitis in a patient with Crohn’s disease on azathioprine therapy. Am J Gastroenterol 2010 Jan;105(1):240-1 Impact factor 2010: 6.0126.882

En 2009 :
- G Fayad, L Legout, V Colombie, T Modine, E Senneville, O Leroy. Aspergillus fumigatus mitral native valve endocarditis. J Heart Valve Dis. 2009 Jul;18(4):472-3. Impact factor 2009 : 1.033
- E Senneville, L Legout, C Loïez, E Beltrand, H Dezèque, H Migaud. Infections ostéo-articulaires : aspects cliniques et modalités de prise en charge. Hygiène 2009. In press. Impact factor 2009 :-
- C Dehecq, X Lemaire, L Legout, E Senneville, Y Yazdanpanah. Infectious complications after the use of angioseal closure device for femoral artery: about 2 cases. Infect Dis Clin Pratice 2009;17(3):191-2. Impact factor 2009: 0.281
- I Uckay, N Vernaz-hegi, S Harbarth, R Stern, L Legout, L Vauthey, T Ferry, A Lubbeke, M Assal, D Lew, P Hoffmeyer, L Bernard. Activity and impact on antibiotic use of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect. 2009 Mar;58(3):205-12. Impact factor 2009: 2.167
- E Senneville, H Morant, D Descamps, S Dekeyser, E Beltrand, B. Singer, M Caillaux, A Boulogne, L Legout, X Lemaire, C Lemaire, Y Yazdanpanah. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in diabetic patients with suspected osteomyelitis of the foot. Clin Infect Dis. 2009 Apr 1;48(7):888-93. Impact factor 2009: 8.195
- S Nguyen, A Pasquet, L Legout, E. Beltrand, L Dubreuil, H Migaud, Y Yazdanpanah, E Senneville. Comparison of the efficacy and tolerance of rifampicin-linezolid versus a rifampicin- cotrimoxazole combination in prolonged oral therapy for bone and joint infections. Clin microbial infect 2009; 15(12):1163-9. Impact factor 2009: 4.014

En 2008 :
- E Senneville, A Lombart, E Beltrand, M Valette, L Legout, M Cazaubiel, Y Yazdanpanah, P Fontaine. Outcome of diabetic foot osteomyelitis treated non-surgically: A retrospective cohort study. Diabetes Care 2008;31(4):637-42 Impact factor 2008: 7.349

En 2007 :
- E Senneville, J Poissy, L Legout, C Dehecq, C Loïez, M Valette, E Beltrand, M Caillaux, Y Mouton, H Migaud, Y Yazdanpanah. Safety of prolonged high-dose levofloxacin therapy for bone infections. J Chemother 2007;19(6): 688-93. Impact factor 2007: 0.922

En 2006 :
- E Senneville, L Legout, M Valette, Y Yazdanpanah, E Beltrand, M Caillaux, H Migaud, Y Mouton. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 2006; 28(8):1155-63. Impact factor 2006: 2.893
- L Legout, E senneville, R Stern, Y Yazdanpanah, C Savage, M Roussel-Delvalez, B Rosele, H Migaud, Y Mouton. Treatment of bone and joint infections due to Gram negative bacilli by a cefepim-fluoroquinolone combination. Clin Microbiol Infect 2006; 12:1030-3. Impact factor 2006: 3.254

- E senneville, H Melliez, E Beltrand, L Legout, M Valette, M Cazaubiel, M Cordonnier, M Caillaux, Y Yazdanpanah, Y Mouton. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab culture. Clin Infect Dis 2006; 42(1):57-62. Impact factor 2006: 6.186
- L Legout , R Stern, M Assal, P Rohner, P Hoffmeyer, L Bernard. Suction drainage culture in managment of muscuskelatel infection. Scand j infect dis 2006; 38(5):341-5. Impact factor 2006: 1.56
- I Uçkay, M Assal , L Legout, P Rohner, R Stern, D Lew, P Hoffemeyer, L Bernard. “recurrent” osteomyelitis with different bacteria without obvious source of reinfection. J Clin Microbiol 2006;44(3):1194-6 Impact factor 2006: 3.445

En 2005:
- C Garzoni, S Emonet, L Legout, B Rilliet, P Hoffmeyer, L Bernard, J Garbino. atypical infections in Tsunami survivors. Emerg Infect Dis 2005;11(10): 1591-3 Impact factor 2005: 5.31
- C Boschin-crinquette, A Kreisler, L Legout, P Charpentier, A Destee, L Defebvre. Can meningoencephalitis be caused by Chlamydia pneumoniae. Rev Neurol (Paris) 2005 ;161(10) :979-83. Impact factor 2005: 0.44
- C Altricher Loan, L Legout, M Assal, P Rohner, P Hoffmeyer, L Bernard. Infections sévères du pied diabétique à Streptococcus agalactae. Rôle délétère du Streptococcus agalactae. Presse Med 2005 ;34(7):491-4. Impact factor 2005: 0.38

En 2004:
- E Senneville, L Legout, M Valette, Y Yazdanpanah, F Giraud, E Beltrand, G Obert, L Dubreuil, H Migaud, Y Mouton. Risk factors for anemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case control study. J antimicrob Chemother 2004 ; 54(4) :798-802. Impact factor 2004: 3.611

Academic positions:

M.D

Research interests:

Osteomyelitis, Orthopaedic infections, Biofilm, Prosthetic vascular graft infection, Devices infection

What I think of the idea behind WebmedCentral:

No idea